Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 19.10.2026 FEXD.LN IE00BWTNMB87 440,903.00 USD 43,842,209.39 99.437 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 19.10.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,434,649.47 28.692 ...
-
Judi Health™ Launches Judi Rx Retire™, a Technology-Enabled Medicare Part D PDP-EGWP for Employer Groups
NEW YORK--(BUSINESS WIRE)--Judi Rx Retire™ is a newly formed PDP-EGWP offering prescription drug coverage to employer groups and their Medicare-eligible retirees....
-
Karman Space & Defense Awarded $218 Million Long-Term Agreement to Support THAAD Production
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Karman Space & Defense (NYSE: KRMN) has entered into a seven-year, $218 million agreement with Lockheed Martin to provide shrouds for the Terminal High Altitude Area Defense (THAAD) program. The long-term commitment provides Karman increased visibility to invest in the people, equipment and manufacturing capacity needed to support growing U.S. and allied demand for THAAD. “Demand for missile defense capabilities is accelerating, and meeting that de...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 19.10.2026 FTEG.LN IE0009F7UB30 125,002.00 EUR 2,664,218.18 21.313 ...
-
Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO 2026
PARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, announced today that Chairman and Chief Executive Officer Pedro Lichtinger will participate in the Longwood Healthcare Leaders Boston CEO meeting, taking place November 2-3 at the Mandarin Oriental in Boston. Lichtinger will join fellow biopharmaceutical leaders for a panel discussion on building global biophar...
-
Spreadshop stellt SPREAD Collection vor: Premium-Bekleidung, entwickelt für ihre Partner
LEIPZIG, Deutschland--(BUSINESS WIRE)--Spreadshop, die kostenlose All-in-one-Lösung für Merch-Shops mit integriertem Print-on-Demand, erweitert ihr Sortiment um die SPREAD Collection, ihre eigene Premium-Bekleidungslinie, die speziell für Spreadshop-Partner entwickelt wurde. Die nahtlos auf die Print-on-Demand-Prozesse von Spreadshop abgestimmte Kollektion umfasst inzwischen 80 Essentials in Europa und 27 in Nordamerika: von Alltags-T-Shirts, schweren Hoodies sowie Oversized- und Cropped-Styles...
-
Spreadshop Introduces SPREAD Collection, Premium Apparel Made for Its Partners
LEIPZIG, Germany--(BUSINESS WIRE)--Spreadshop, the free all-in-one merch shop solution with built-in print on demand, is expanding its product range with SPREAD Collection, its premium in-house apparel line developed specifically for Spreadshop partners. Designed to work seamlessly with Spreadshop’s print-on-demand processes, the collection now counts 80 essentials in Europe and 27 in North America, from everyday tees, heavyweight hoodies, oversized and cropped styles to tops, bottoms and kidsw...
-
Morgan Stanley Capital Partners Acquires The Rapid Group
NEW YORK--(BUSINESS WIRE)--Investment funds managed by Morgan Stanley Capital Partners (MSCP), the middle market private equity buyout team within Morgan Stanley Investment Management, announced today the acquisition of The Rapid Group (TRG), a leading provider of inspection, repair and maintenance services for rotating equipment across municipal, commercial and industrial end markets. Headquartered in Paterson, New Jersey, TRG serves more than 1,800 customers across a range of public- and priv...
-
Algia Pharma Reports Positive Topline Results From IND-Enabling Study of AlgiaPak® for Non-Opioid Treatment of Mild-to-Moderate Acute Pain
BOCA RATON, Fla.--(BUSINESS WIRE)--Algia Pharma, LLC (“Algia”) today announced the successful completion of its Investigational New Drug (IND)-enabling preclinical toxicology study for AlgiaPak®. AlgiaPak is a hospital-grade multimodal pain regimen designed to treat all mild-to-moderate acute pain as effectively as opioids, without exposing patients to the risk of opioid addiction. Results from the study, conducted in full compliance with Good Laboratory Practice (GLP) standards, demonstrated t...